Join Now

Yearly Archives: 2024

Utah Legislative Recap, Feb. 9, 2024

By admin | Published February 8, 2024

Funding Requests   Life Sciences Initiative – Senator Ann Millner The original initiative requested the legislature provide $7.125M of ongoing funding to higher education in Utah to support the workforce needs of Utah’s Life Sciences industry.  BioUtah has worked closely with Talent Ready Utah, colleges and universities in the state, and other stakeholders to create […]

Posted in BioUtah News | Comments Off on Utah Legislative Recap, Feb. 9, 2024

2024 Life Sciences Day on the Hill Recap

By admin | Published February 8, 2024

Utah’s vibrant life sciences industry was on full display February 7 as part of BioUtah’s “Life Sciences Day on the Hill”. The event, a collarboration with the Governor’s Office of Economic Opportunity, (GOEO) was held at the state capitol. 29 companies exhibited their innovative technologies in the capitol rotunda, which provided legislators the opportunity to […]

Posted in BioUtah News | Comments Off on 2024 Life Sciences Day on the Hill Recap

Eris Biotech accepted to Y Combinator

By Natalie Themm | Published February 8, 2024

Eris Biotech accepted to Y Combinator

Posted in BioUtah News | Tagged | Comments Off on Eris Biotech accepted to Y Combinator

Clene Inc. Reports ‘Unprecedented,’ Statistically Significant Long-Term Clinical Improvements for VISIONARY-MS Trial Participants with Stable Relapsing-Remitting MS

By Natalie Themm | Published February 8, 2024

Clene Inc. (NASDAQ: CLNN) Reports ‘Unprecedented,’ Statistically Significant Long-Term Clinical Improvements for VISIONARY-MS Trial Participants with Stable Relapsing-Remitting MS

Posted in BioUtah News | Tagged | Comments Off on Clene Inc. Reports ‘Unprecedented,’ Statistically Significant Long-Term Clinical Improvements for VISIONARY-MS Trial Participants with Stable Relapsing-Remitting MS

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

By Natalie Themm | Published February 8, 2024

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

Posted in BioUtah News | Tagged | Comments Off on Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

Halia Therapeutics Announces Collaboration with Canary Speech to Leverage its Cutting Edge AI- Driven Speech Technology to Advance the Clinical Development of Novel Therapeutics Targeting Neuroinflammation

By Natalie Themm | Published February 8, 2024

This technology will support the development of Halia’s new Alzheimer’s disease drug, HT-4253, targeting a mediator of neuroinflammation called Leucine-rich repeat kinase 2 (LRRK2)

Posted in BioUtah News | Tagged | Comments Off on Halia Therapeutics Announces Collaboration with Canary Speech to Leverage its Cutting Edge AI- Driven Speech Technology to Advance the Clinical Development of Novel Therapeutics Targeting Neuroinflammation

AdvaMed Announces New Chair of State Medtech Alliance

By Natalie Themm | Published February 8, 2024

AdvaMed Announces New Chair of State Medtech Alliance

Posted in BioUtah News | Tagged | Comments Off on AdvaMed Announces New Chair of State Medtech Alliance

Halia Therapeutics Announces $30M Series C Financing to Advance Novel Pipeline of Anti-Inflammatory Therapeutics

By admin | Published February 1, 2024

Funds will support the advancement of lead programs in Phase II clinical trials, evaluating HT-6184, Halia’s first-in-class NLRP3/NEK7 inflammasome inhibitor, and advancing additional programs into the clinic. LEHI, Utah, Jan. 31, 2024 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, today announced the completion […]

Posted in Policy News | Comments Off on Halia Therapeutics Announces $30M Series C Financing to Advance Novel Pipeline of Anti-Inflammatory Therapeutics

AI Utah Annouces Inaugural AI Utah 100 List

By Natalie Themm | Published February 1, 2024

AI Utah Annouces Inaugural AI Utah 100 List

Posted in BioUtah News | Tagged | Comments Off on AI Utah Annouces Inaugural AI Utah 100 List

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

By Natalie Themm | Published February 1, 2024

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health

By Natalie Themm | Published February 1, 2024

Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health

Posted in BioUtah News | Tagged | Comments Off on Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health

Utah Innovation Fund invests $700k in local healthcare, life sciences startups

By Natalie Themm | Published February 1, 2024

Utah Innovation Fund invests $700k in local healthcare, life sciences startups

Posted in BioUtah News | Tagged | Comments Off on Utah Innovation Fund invests $700k in local healthcare, life sciences startups

A Special Thanks To Our Legacy and Platinum Elite Members